Laboratory Reference Grade Compounds

Semax + Selank Stack (Dual-Vial Nootropic Kit)

RUO In-VitroLyophilized Powder≥99% Reference Standard
Protocol SOP↓
₱4,190.00
Out of stock
Net Content20MG
InclusionAnalytical Lab Set
1
Semax + Selank Stack (Dual-Vial Nootropic Kit)20MG · Analytical Lab Set
₱4,190.00
1
Technical Specification & Protocol Dossier

Analytical Standards & Laboratory Handling

Verified laboratory protocols, reconstitution parameters, and handling guidelines.

P

Pharmacological Profile & Mechanism of Action

Research Monograph

What it is: The premier cognitive enhancement and neurogenic research stack pairing Semax (10mg ACTH 4-10 analogue) and Selank (10mg synthetic tuftsin analogue) in two separate sterile analytical vials.

How it works: Semax acts as a potent central nervous system stimulant and neurotrophin inducer, triggering rapid upregulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in hippocampal neurons to enhance synaptic plasticity and executive focus. Selank functions as a calming peptide anxiolytic, modulating GABA-A receptor sensitivity and slowing the enzymatic degradation of endogenous enkephalins to neutralize anxiety and mental fatigue without sedation or addiction potential.

CRITICAL LABORATORY RECONSTITUTION & ASSAY HANDLING: Reconstitute both vials separately. Semax is administered in the morning for cognitive drive; Selank is administered in the afternoon or evening for stress mitigation.

Compound & Molecular Specifications

Certificate of Analysis Standards
Target CategoryCognitive & Neuroprotective
Intended ApplicationLaboratory & In-Vitro Research Only (RUO)
Physical StateLyophilized Solid Powder
Purity Specification≥99.0% (Dual Individual HPLC Certified)
Net Content Options20MG
Inclusion PackagesVial Only, Vial + BAC Water, Analytical Lab Set
⚡ Pharmacodynamic Synergy·Verified Stacking Regimens

Frequently Stacked with Semaglutide

Clinically verified combinations activating complementary physiological pathways without receptor competition.

Stacking Studio
Co-Administered Regimen

Cagrilintide (Amylin Analogue)

+99 Synergy
The CagriSema Protocol: Coordinated Amylin + GLP-1 Incretin Synergy

Cagrilintide engages area postrema and ventral tegmental amylin receptors while Semaglutide stimulates hypothalamic GLP-1 receptors, producing multiplicative appetite suppression and glycemic control superior to either monotherapy.

⏱Co-administered once weekly on the same day•🛡Separate syringe
15% Off bundle
Compare
Co-Administered Regimen

BPC-157 (Pentadecapeptide)

+90 Synergy
GLP-1 Gut Barrier & Epithelial Recovery Stack

Semaglutide delays gastric motility to enhance satiety. BPC-157 upregulates tight junction proteins (Claudin, Zonula Occludens) and nitric oxide synthesis, minimizing digestive cramping and acid reflux in GLP-1 naive subjects.

⏱Semaglutide: Weekly SubQ•🛡Separate syringe
15% Off bundle
Compare
⚠️ Critical Safety Contraindication Warning:
Semaglutide is contraindicated to stack concurrently with Tirzepatide, Retatrutide. Both agents compete for the same receptor beds, risking severe adverse compounding without additive efficacy.